Literature DB >> 11264898

Iron induces Bcl-2 expression in human dermal microvascular endothelial cells.

T Simonart1, C Degraef, P Stordeur, J C Noel, R Mosselmans, J P Van Vooren, D Parent, J R Boelaert, M Heenen, P Galand.   

Abstract

Iron is suspected to be involved in the induction and/or progression of various human tumors. The present study was designed to investigate the effects of iron on endothelial cells, keeping in mind that the homeostasis of microvessels plays a critical role in neo-angiogenesis. Applying a model of human dermal microvascular endothelial cell terminal differentiation and death induced by serum deprivation, we found that iron salts (iron chloride and ferric nitrilotriacetate) provided a survival advantage to endothelial cells. Using immunohistochemistry and Western Blot analysis, we found that the extended cellular life span induced by iron was paralleled by an increase of Bcl-2 protein expression. Taken together, these observations suggest that iron may give a survival advantage to endothelial cells and represent a novel mechanism through which iron may contribute to tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11264898     DOI: 10.1080/10715760100300211

Source DB:  PubMed          Journal:  Free Radic Res        ISSN: 1029-2470


  5 in total

1.  NPS6, encoding a nonribosomal peptide synthetase involved in siderophore-mediated iron metabolism, is a conserved virulence determinant of plant pathogenic ascomycetes.

Authors:  Shinichi Oide; Wolfgang Moeder; Stuart Krasnoff; Donna Gibson; Hubertus Haas; Keiko Yoshioka; B Gillian Turgeon
Journal:  Plant Cell       Date:  2006-10-20       Impact factor: 11.277

2.  Iron inhibits neurotoxicity induced by trace copper and biological reductants.

Authors:  Anthony R White; Kevin J Barnham; Xudong Huang; Irene Voltakis; Konrad Beyreuther; Colin L Masters; Robert A Cherny; Ashley I Bush; Roberto Cappai
Journal:  J Biol Inorg Chem       Date:  2004-02-03       Impact factor: 3.358

3.  A hemochromatosis-causing mutation C282Y is a risk factor for proliferative diabetic retinopathy in Caucasians with type 2 diabetes.

Authors:  Borut Peterlin; Mojca Globočnik Petrovič; Jana Makuc; Marko Hawlina; Daniel Petrovič
Journal:  J Hum Genet       Date:  2003-11-15       Impact factor: 3.172

4.  Prevalence, characteristics, and prognostic significance of HFE gene mutations in type 2 diabetes: the Fremantle Diabetes Study.

Authors:  Timothy M E Davis; John Beilby; Wendy A Davis; John K Olynyk; Gary P Jeffrey; Enrico Rossi; Conchita Boyder; David G Bruce
Journal:  Diabetes Care       Date:  2008-06-19       Impact factor: 19.112

5.  Iron: a target for the management of Kaposi's sarcoma?

Authors:  Thierry Simonart
Journal:  BMC Cancer       Date:  2004-01-15       Impact factor: 4.430

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.